CRISPR
Jumpcode Genomics, TGen Partner to Test Metagenomic Approaches for COVID Detection
The company and institute are collaborating on the development of a diagnostic assay that uses Jumpcode's CRISPR-based reagents and TGen's NGS technology.
The point-of-care system can detect SARS-CoV-2 in unprocessed patient saliva in about an hour, according to the researchers.
Synthetic biology and CRISPR have enabled researchers to develop wearable sensors that can detect a variety of viruses and bacteria, including SARS-CoV-2.
SMART Team Improves Virus Detection Speed With Quantitative CRISPR-Based Isothermal Amplification
Premium
Originally developed to detect contamination of cell therapy products, the method combines CRISPR and PCR technology and can be used to quantify viral loads.
Sherlock Biosciences Foundation Grants License to Rokline Health for COVID-19 CRISPR Tests
Sherlock Biosciences said that under the agreement, Rokline Health will develop and manufacture high-throughput CRISPR kits in the US.
Apr 26, 2021